Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Junxun Ma

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109902284. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune … Co-author DOI 10.3389/fonc.2021.585271↗
  2. Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients. Co-author DOI 10.1007/s00262-019-02452-3↗
  3. Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort. First author DOI 10.2147/tcrm.s173041↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Hu · 2 shared papers, 2018–2021 · strength 0.20
  2. Danyang Sun · 2 shared papers, 2018–2020 · strength 0.16
  3. Jin Shang · 1 shared paper, 2021 · strength 0.13
  4. Haitao Tao · 1 shared paper, 2021 · strength 0.13
  5. Yi Hu · 1 shared paper, 2020 · strength 0.09
  6. Fan Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.